Trial Profile
A PHASE II, MULTI-CENTER, OPEN LABEL STUDY OF CLINICAL PHARMACOLOGY, SAFETY, AND TOLERABILITY OF ZIPRASIDONE IN PATIENTS WITH SCHIZOPHRENIA
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 23 May 2016
Price :
$35
*
At a glance
- Drugs Ziprasidone (Primary)
- Indications Schizophrenia
- Focus Adverse reactions
- Sponsors Meiji Seika Pharma
- 16 Jan 2015 New trial record